0.7876
Longeveron Inc stock is traded at $0.7876, with a volume of 326.88K.
It is down -0.93% in the last 24 hours and up +15.74% over the past month.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
See More
Previous Close:
$0.795
Open:
$0.775
24h Volume:
326.88K
Relative Volume:
0.35
Market Cap:
$10.79M
Revenue:
$1.89M
Net Income/Loss:
$-17.92M
P/E Ratio:
-0.1177
EPS:
-6.69
Net Cash Flow:
$-15.62M
1W Performance:
-0.53%
1M Performance:
+15.74%
6M Performance:
-53.67%
1Y Performance:
-61.01%
Longeveron Inc Stock (LGVN) Company Profile
Name
Longeveron Inc
Sector
Industry
Phone
305-302-7158
Address
1951 NW 7TH AVENUE, MIAMI
Compare LGVN with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
LGVN
Longeveron Inc
|
0.7876 | 16.64M | 1.89M | -17.92M | -15.62M | -6.69 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Longeveron Inc Stock (LGVN) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-06-24 | Initiated | ROTH MKM | Buy |
Longeveron Inc Stock (LGVN) Latest News
Technical analysis overview for Longeveron Inc. stockShare Buyback & Fast Gain Stock Tips - Newser
Analyzing recovery setups for Longeveron Inc. investorsWeekly Trend Report & Safe Capital Growth Plans - Newser
Can Longeveron Inc. hit a new high this monthJuly 2025 Decliners & Short-Term Trading Opportunity Alerts - Newser
Multi factor analysis applied to Longeveron Inc.Portfolio Risk Report & Safe Entry Trade Signal Reports - Newser
Long term hold vs stop loss in Longeveron Inc.2025 Winners & Losers & Weekly Consistent Profit Watchlists - Newser
Relative strength of Longeveron Inc. in sector analysisMarket Volume Report & Capital Efficient Trade Techniques - Newser
Identifying reversal signals in Longeveron Inc.Earnings Summary Report & Community Trade Idea Sharing - Newser
Market reaction to Longeveron Inc.’s recent newsMarket Sentiment Report & Safe Swing Trade Setups - Newser
How to build a custom watchlist for Longeveron Inc.Treasury Yields & Advanced Swing Trade Entry Alerts - Newser
Measuring Longeveron Inc.’s beta against major indices2025 Market Sentiment & Fast Moving Stock Trade Plans - Newser
Price momentum metrics for Longeveron Inc. explainedEarnings Miss & Low Risk High Reward Ideas - Newser
Using fundamentals and technicals on Longeveron Inc.Market Risk Analysis & Real-Time Stock Entry Alerts - Newser
Using data filters to optimize entry into Longeveron Inc.Market Volume Report & Weekly Chart Analysis and Trade Guides - Newser
Tools to monitor Longeveron Inc. recovery probabilityOptions Play & Weekly Return Optimization Plans - Newser
Why Longeveron Inc. is moving todayJuly 2025 PreEarnings & Precise Swing Trade Entry Alerts - Newser
Is Longeveron Inc. forming a bottoming baseDip Buying & High Accuracy Swing Entry Alerts - Newser
Using Bollinger Bands to evaluate Longeveron Inc.July 2025 Patterns & Technical Entry and Exit Alerts - Newser
Volatility clustering patterns for Longeveron Inc.2025 Momentum Check & Verified High Yield Trade Plans - Newser
Risk vs reward if holding onto Longeveron Inc.Market Performance Recap & Risk Controlled Swing Trade Alerts - Newser
Comparing Longeveron Inc. in custom built stock radars2025 Market WrapUp & Long-Term Capital Growth Strategies - Newser
Published on: 2025-09-09 22:55:06 - Newser
How to manage a losing position in Longeveron Inc.Bear Alert & AI Powered Buy/Sell Recommendations - Newser
Alzheimer’s Disease Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | GliaPharm, Galimedix, Oligomerix, Artery Therapeutics, Longeveron - Barchart.com
Is Longeveron Inc. still a buy after recent gainsJuly 2025 Volume & Safe Capital Allocation Plans - beatles.ru
Longeveron Inc. Flashes Rebound Signal in Oversold ConditionJuly 2025 Snapshot & Technical Entry and Exit Alerts - beatles.ru
Chart based analysis of Longeveron Inc. trendsJuly 2025 PostEarnings & Weekly Market Pulse Alerts - Newser
Buybacks Report: Is Longeveron Inc.’s growth already priced inOptions Play & Real-Time Sentiment Analysis - خودرو بانک
Can Longeveron Inc. deliver consistent dividendsJuly 2025 Closing Moves & Short-Term High Return Ideas - خودرو بانک
Analysts Offer Insights on Healthcare Companies: Novan (NOVN) and Longeveron (LGVN) - The Globe and Mail
Will Longeveron Inc. benefit from rate cutsJuly 2025 Trade Ideas & Stepwise Trade Execution Plans - خودرو بانک
Can swing trading help recover from Longeveron Inc. lossesMarket Movement Recap & High Conviction Buy Zone Alerts - Newser
Does Longeveron Inc. outperform in volatile markets2025 Biggest Moves & Growth Focused Entry Point Reports - خودرو بانک
News impact scoring models applied to Longeveron Inc.Weekly Market Report & Precise Entry and Exit Recommendations - Newser
What does recent volatility data suggest for Longeveron Inc.Trend Reversal & Safe Capital Growth Trade Ideas - Newser
Longeveron Announces Leadership Changes Amidst CEO Departure - MSN
Short interest data insights for Longeveron Inc.Market Trend Summary & Daily Stock Trend Reports - Newser
Longeveron Inc Stock (LGVN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):